SERVICES
Collection of ~2000 clinical strains (~400 drug-resistant bacterium).
Established multiple in vivo/in vitro assays to evaluate novel antimicrobial compounds
Completed screening tests for ~500 compounds and preclinical research of ~80 compounds,some of which have been approved for clinical trials by NMPA
Gram-Positive Bacteria (~800 strains) | Gram-Negative Bacteria (~1000 strains) | Fungi (~200 strains) |
---|---|---|
Staphylococcus aureus (MRSA, MSSA) Staphylococcus epidermis(MRSE, MSSE) Streptococcus (PRSP, PSSP) Enterococcus faecium (VRE) Enterococcus faecalis (VRE) Clostridium difficile |
Escherichia coli (ESBLs,CRE) Klebsiella pneumoniae ( ESBLs,KPC) Moraxella catarrhalis Haemophilus influenzae Enterobacter cloacae Enterobacter aerogenes Acinetobacter baumannii (OXA23,integron type I) Proteusbacillus vulgaris Salmonella typhi Pseudomonas aeruginosa (Integron type I, IMP4) Salmonella |
Candida krusei Candida tropicalis Candida albicans Candida parapsilosis Aspergillus niger |
--MIC,MIC50,MIC90,MICrange
--MBC,MBC50,MBC90,MBCrange
--KC,SBA
--FIC
Clostridium difficile-associated diarrhea (CDAD) Hamster Model
Lung Infection Models
Thigh Infection Models
Systemic Infection Models(bacteria/fungi)
Others (Subdermal Infection Models/Renal Infection Models/Corneal Infection Models /Vaginal Infection Models/Scalded Skin Infection Models)
Tel : 028-8592-1823 (in China)
Tel:+1-517-388-6508 (in US)
Tel : +86 (28) 8592-1823 (outside of China)
Fax : +86-28-62491302
Zip code : 610041
Address: No.88, Keyuan South Road, Hi-tech Zone, Chengdu, Sichuan Province, China